{"id":"https://openalex.org/W4205614799","doi":"https://doi.org/10.1111/dom.14640","title":"Efficacy and safety of high\u2010dose glucagon\u2010like peptide\u20101, glucagon\u2010like peptide\u20101/glucose\u2010dependent insulinotropic peptide, and glucagon\u2010like peptide\u20101/glucagon receptor agonists in type 2 diabetes","display_name":"Efficacy and safety of high\u2010dose glucagon\u2010like peptide\u20101, glucagon\u2010like peptide\u20101/glucose\u2010dependent insulinotropic peptide, and glucagon\u2010like peptide\u20101/glucagon receptor agonists in type 2 diabetes","alternate_titles":[],"publication_year":2022,"publication_date":"2022-01-05","ids":{"openalex":"https://openalex.org/W4205614799","doi":"https://doi.org/10.1111/dom.14640","pmid":"https://pubmed.ncbi.nlm.nih.gov/34984793"},"language":"en","primary_location":{"id":"doi:10.1111/dom.14640","doi":"https://doi.org/10.1111/dom.14640","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dom.14640","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4205614799"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032977803","display_name":"Christophe E.M. De Block","orcid":"https://orcid.org/0000-0002-0679-3203","observed_orcids":["https://orcid.org/0000-0002-0679-3203"]},"institutions":[{"id":"https://openalex.org/I149213910","display_name":"University of Antwerp","ror":"https://ror.org/008x57b05","country_code":"BE","type":"education","lineage":["https://openalex.org/I149213910"]},{"id":"https://openalex.org/I4210102047","display_name":"Antwerp University Hospital","ror":"https://ror.org/01hwamj44","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210102047"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"Christophe E. M. De Block","raw_affiliation_strings":["Department of Endocrinology, Diabetology & Metabolism Antwerp University Hospital, University of Antwerp Edegem Belgium","Faculty of Medicine & Health Sciences, Laboratory of Experimental Medicine and Paediatrics (LEMP) University of Antwerp Wilrijk Belgium"],"raw_orcid":"https://orcid.org/0000-0002-0679-3203","affiliations":[{"raw_affiliation_string":"Department of Endocrinology, Diabetology & Metabolism Antwerp University Hospital, University of Antwerp Edegem Belgium","institution_ids":["https://openalex.org/I149213910","https://openalex.org/I4210102047"]},{"raw_affiliation_string":"Faculty of Medicine & Health Sciences, Laboratory of Experimental Medicine and Paediatrics (LEMP) University of Antwerp Wilrijk Belgium","institution_ids":["https://openalex.org/I149213910"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005063608","display_name":"Eveline Lia Dirinck","orcid":"https://orcid.org/0000-0002-5211-2210","observed_orcids":["https://orcid.org/0000-0002-5211-2210"]},"institutions":[{"id":"https://openalex.org/I149213910","display_name":"University of Antwerp","ror":"https://ror.org/008x57b05","country_code":"BE","type":"education","lineage":["https://openalex.org/I149213910"]},{"id":"https://openalex.org/I4210102047","display_name":"Antwerp University Hospital","ror":"https://ror.org/01hwamj44","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210102047"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Eveline Dirinck","raw_affiliation_strings":["Department of Endocrinology, Diabetology & Metabolism Antwerp University Hospital, University of Antwerp Edegem Belgium","Faculty of Medicine & Health Sciences, Laboratory of Experimental Medicine and Paediatrics (LEMP) University of Antwerp Wilrijk Belgium"],"raw_orcid":"https://orcid.org/0000-0002-5211-2210","affiliations":[{"raw_affiliation_string":"Department of Endocrinology, Diabetology & Metabolism Antwerp University Hospital, University of Antwerp Edegem Belgium","institution_ids":["https://openalex.org/I149213910","https://openalex.org/I4210102047"]},{"raw_affiliation_string":"Faculty of Medicine & Health Sciences, Laboratory of Experimental Medicine and Paediatrics (LEMP) University of Antwerp Wilrijk Belgium","institution_ids":["https://openalex.org/I149213910"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025451391","display_name":"Ann A. Verhaegen","orcid":"https://orcid.org/0000-0003-2130-7776","observed_orcids":["https://orcid.org/0000-0003-2130-7776"]},"institutions":[{"id":"https://openalex.org/I149213910","display_name":"University of Antwerp","ror":"https://ror.org/008x57b05","country_code":"BE","type":"education","lineage":["https://openalex.org/I149213910"]},{"id":"https://openalex.org/I4210102047","display_name":"Antwerp University Hospital","ror":"https://ror.org/01hwamj44","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210102047"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Ann Verhaegen","raw_affiliation_strings":["Department of Endocrinology, Diabetology & Metabolism Antwerp University Hospital, University of Antwerp Edegem Belgium","Faculty of Medicine & Health Sciences, Laboratory of Experimental Medicine and Paediatrics (LEMP) University of Antwerp Wilrijk Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology, Diabetology & Metabolism Antwerp University Hospital, University of Antwerp Edegem Belgium","institution_ids":["https://openalex.org/I149213910","https://openalex.org/I4210102047"]},{"raw_affiliation_string":"Faculty of Medicine & Health Sciences, Laboratory of Experimental Medicine and Paediatrics (LEMP) University of Antwerp Wilrijk Belgium","institution_ids":["https://openalex.org/I149213910"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111609726","display_name":"Luc F. Van Gaal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I149213910","display_name":"University of Antwerp","ror":"https://ror.org/008x57b05","country_code":"BE","type":"education","lineage":["https://openalex.org/I149213910"]},{"id":"https://openalex.org/I4210102047","display_name":"Antwerp University Hospital","ror":"https://ror.org/01hwamj44","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210102047"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Luc F. Van Gaal","raw_affiliation_strings":["Department of Endocrinology, Diabetology & Metabolism Antwerp University Hospital, University of Antwerp Edegem Belgium","Faculty of Medicine & Health Sciences, Laboratory of Experimental Medicine and Paediatrics (LEMP) University of Antwerp Wilrijk Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology, Diabetology & Metabolism Antwerp University Hospital, University of Antwerp Edegem Belgium","institution_ids":["https://openalex.org/I149213910","https://openalex.org/I4210102047"]},{"raw_affiliation_string":"Faculty of Medicine & Health Sciences, Laboratory of Experimental Medicine and Paediatrics (LEMP) University of Antwerp Wilrijk Belgium","institution_ids":["https://openalex.org/I149213910"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5032977803"],"corresponding_institution_ids":["https://openalex.org/I149213910","https://openalex.org/I4210102047"],"apc_list":{"value":4800,"currency":"USD","value_usd":4800},"apc_paid":null,"fwci":0.8693,"has_fulltext":false,"cited_by_count":37,"citation_normalized_percentile":{"value":0.69516044,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"24","issue":"5","first_page":"788","last_page":"805"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9819999933242798},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9580000042915344},{"id":"https://openalex.org/keywords/gip-glp-1-receptor-agonist","display_name":"GIP/GLP-1 receptor agonist","score":0.722000002861023},{"id":"https://openalex.org/keywords/tirzepatide","display_name":"tirzepatide","score":0.9869999885559082},{"id":"https://openalex.org/keywords/hba1c-control","display_name":"HbA1c control","score":0.781000018119812},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.8510000109672546},{"id":"https://openalex.org/keywords/gastrointestinal-side-effects","display_name":"gastrointestinal adverse effects","score":0.8159999847412109},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.8199999928474426},{"id":"https://openalex.org/keywords/cardiovascular-outcomes","display_name":"cardiovascular outcomes","score":0.5770000219345093},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.6880000233650208},{"id":"https://openalex.org/keywords/normoglycemia","display_name":"normoglycemia","score":0.6589999794960022}],"concepts":[{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.7890017032623291},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.7106455564498901},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6764671206474304},{"id":"https://openalex.org/C2778563252","wikidata":"https://www.wikidata.org/wiki/Q170617","display_name":"Glucagon","level":3,"score":0.6704196929931641},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6520376205444336},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.640981137752533},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.6082775592803955},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6057557463645935},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5428294539451599},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4786478281021118},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.46156683564186096},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4163268208503723},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.3537974953651428}],"mesh":[{"descriptor_ui":"D000097789","descriptor_name":"Glucagon-Like Peptide-1 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005749","descriptor_name":"Gastric Inhibitory Polypeptide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/dom.14640","doi":"https://doi.org/10.1111/dom.14640","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dom.14640","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:34984793","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34984793","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":108,"referenced_works":["https://openalex.org/W172609984","https://openalex.org/W1526927233","https://openalex.org/W1592686897","https://openalex.org/W1798757189","https://openalex.org/W1964607854","https://openalex.org/W1964872621","https://openalex.org/W1967295307","https://openalex.org/W1969932276","https://openalex.org/W2003198450","https://openalex.org/W2005501262","https://openalex.org/W2022614952","https://openalex.org/W2028502361","https://openalex.org/W2038548962","https://openalex.org/W2057235055","https://openalex.org/W2079429014","https://openalex.org/W2085655607","https://openalex.org/W2095235238","https://openalex.org/W2096048424","https://openalex.org/W2111824270","https://openalex.org/W2114102308","https://openalex.org/W2117764934","https://openalex.org/W2122333141","https://openalex.org/W2131112248","https://openalex.org/W2135854640","https://openalex.org/W2143612861","https://openalex.org/W2144125787","https://openalex.org/W2147872784","https://openalex.org/W2150012656","https://openalex.org/W2158666727","https://openalex.org/W2171294019","https://openalex.org/W2261184724","https://openalex.org/W2283809486","https://openalex.org/W2294054989","https://openalex.org/W2309242694","https://openalex.org/W2317095451","https://openalex.org/W2337454357","https://openalex.org/W2345478245","https://openalex.org/W2411975823","https://openalex.org/W2414002317","https://openalex.org/W2443999297","https://openalex.org/W2471889258","https://openalex.org/W2519803668","https://openalex.org/W2567362164","https://openalex.org/W2567497498","https://openalex.org/W2572398654","https://openalex.org/W2581264645","https://openalex.org/W2591832038","https://openalex.org/W2597545061","https://openalex.org/W2609075277","https://openalex.org/W2737611067","https://openalex.org/W2741958922","https://openalex.org/W2750733474","https://openalex.org/W2773791657","https://openalex.org/W2784276839","https://openalex.org/W2787255324","https://openalex.org/W2788057966","https://openalex.org/W2788154323","https://openalex.org/W2790252631","https://openalex.org/W2803869903","https://openalex.org/W2808958607","https://openalex.org/W2886911834","https://openalex.org/W2895135221","https://openalex.org/W2895666357","https://openalex.org/W2900829579","https://openalex.org/W2905361067","https://openalex.org/W2915948028","https://openalex.org/W2940783197","https://openalex.org/W2943546226","https://openalex.org/W2948261890","https://openalex.org/W2978840913","https://openalex.org/W2979558564","https://openalex.org/W2981305821","https://openalex.org/W2982363774","https://openalex.org/W2989619493","https://openalex.org/W2990725177","https://openalex.org/W2993111138","https://openalex.org/W3004172664","https://openalex.org/W3010125829","https://openalex.org/W3011482816","https://openalex.org/W3012065601","https://openalex.org/W3013979982","https://openalex.org/W3017015779","https://openalex.org/W3027852565","https://openalex.org/W3028216699","https://openalex.org/W3087889571","https://openalex.org/W3088051473","https://openalex.org/W3108676144","https://openalex.org/W3119307884","https://openalex.org/W3127462604","https://openalex.org/W3133746780","https://openalex.org/W3160773731","https://openalex.org/W3165203237","https://openalex.org/W3173551155","https://openalex.org/W3174970167","https://openalex.org/W3177122952","https://openalex.org/W3177393241","https://openalex.org/W3184243270","https://openalex.org/W3185437491","https://openalex.org/W3191712049","https://openalex.org/W3195404919","https://openalex.org/W3199000562","https://openalex.org/W3205201678","https://openalex.org/W3209243563","https://openalex.org/W4253366698","https://openalex.org/W4253996779","https://openalex.org/W4294215472","https://openalex.org/W6749374933","https://openalex.org/W7018854752"],"related_works":["https://openalex.org/W7167572905","https://openalex.org/W7164675315","https://openalex.org/W2152969995","https://openalex.org/W2563047690","https://openalex.org/W7160435453","https://openalex.org/W4404975677","https://openalex.org/W4280579438","https://openalex.org/W2123041020","https://openalex.org/W4401254658","https://openalex.org/W3090176981"],"abstract_inverted_index":{"Glucagon-like":[0],"peptide-1":[1,70],"receptor":[2,71,74],"agonists":[3],"(GLP-1":[4],"RAs)":[5],"have":[6],"become":[7],"agents":[8],"of":[9,32,38,46,61,85,93,105,130,137,145,171,178,185,194,203,217,233],"choice":[10],"for":[11,52],"people":[12,131,234],"with":[13,18,115,123,125,132,159,241,247],"type":[14],"2":[15,201],"diabetes":[16],"(T2D)":[17],"established":[19],"cardiovascular":[20,257],"disease":[21],"or":[22,80,147,163,209],"in":[23,192,211,230],"high-risk":[24],"individuals.":[25],"With":[26],"currently":[27],"available":[28],"GLP-1":[29,117,161,187,219],"RAs,":[30],"51%-79%":[31],"subjects":[33],"achieve":[34],"an":[35,135],"HbA1c":[36,103,136,236],"target":[37,104],"less":[39,106,138],"than":[40,107,139],"7.0%":[41,108],"and":[42,82,119,155,168,189,213,221,237,259],"4%-27%":[43],"lose":[44],"10%":[45,146],"body":[47,142,238],"weight,":[48],"illustrating":[49],"the":[50,66,98,172,199,204,222],"need":[51],"more":[53],"potent":[54],"agents.":[55],"Three":[56],"databases":[57],"(PubMed,":[58],"Cochrane,":[59],"Web":[60],"Science)":[62],"were":[63],"searched":[64],"using":[65,89,97],"MESH":[67],"terms":[68],"'glucagon-like":[69],"agonist',":[72,75],"'glucagon":[73],"'glucose-dependent":[76],"insulinotropic":[77,225],"peptide',":[78],"'dual":[79],"co-agonist',":[81],"'tirzepatide'.":[83],"Quality":[84],"papers":[86],"was":[87,95,109,149],"scored":[88],"PRISMA":[90],"guidelines.":[91],"Risk":[92],"bias":[94],"evaluated":[96],"Cochrane":[99],"assessment":[100],"tool.":[101],"An":[102],"attained":[110],"by":[111,151],"up":[112,120,127,152,156,242],"to":[113,121,128,153,157,243,255,264],"80%":[114],"high-dose":[116,160,186,218],"RAs":[118,162,188,220],"97%":[122],"tirzepatide,":[124,164],"even":[126],"62%":[129,244],"T2D":[133],"reaching":[134,235],"5.7%.":[140],"A":[141],"weight":[143,239],"loss":[144],"greater":[148],"obtained":[150],"50%":[154],"69%":[158],"respectively.":[165],"The":[166,215],"glucose-":[167],"weight-lowering":[169],"effects":[170,184],"GLP-1/glucagon":[173],"RA":[174,227],"cotadutide":[175],"equal":[176],"those":[177],"liraglutide":[179],"1.8":[180],"mg.":[181],"Gastrointestinal":[182],"side":[183],"co-agonists":[190],"occurred":[191],"30%-70%":[193],"patients,":[195],"mostly":[196],"arising":[197],"within":[198],"first":[200,205],"weeks":[202],"dose,":[206],"being":[207],"mild":[208],"moderate":[210],"severity,":[212],"transient.":[214],"development":[216],"dual":[223],"GLP-1/glucose-dependent":[224],"peptide":[226],"tirzepatide":[228],"resulted":[229],"increasing":[231],"numbers":[232],"targets,":[240],"attaining":[245],"normoglycaemia":[246],"15-mg":[248],"tirzepatide.":[249],"Whether":[250],"this":[251],"will":[252],"also":[253],"translate":[254],"better":[256],"outcomes":[258],"affect":[260],"treatment":[261],"guidelines":[262],"remains":[263],"be":[265],"studied.":[266]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4205614799","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":8},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2022-01-26T00:00:00"}
